United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News Qualcomm’s CEO charts AI-led future as trade turbulence and handset volatility challenge outlook Qualcomm’s Q2 FY25 earnings call spotlighted the company's AI-centric strategy, automotive wins, and Snapdragon expansion, while executives cautioned on macroeconomic risks and evolving tariff threats. byPallavi MadhirajuMay 3, 2025